Table 1.
Outcomes | Counts | Frequency among 117 studies |
---|---|---|
Asthma symptom severity/ asthma control | 54 | 46% |
Adverse events | 44 | 38% |
Change in Pre-bronchodilator FEV1 | 43 | 37% |
Forced expiratory volume-one second, FEV1 | 41 | 35% |
Change in ACQ scale | 40 | 34% |
Rescue medication use | 32 | 27% |
Change in Peak expiratory flow (PEF) (lung function) | 31 | 26% |
Health-related quality of life (HRQoL) | 30 | 26% |
Rate of (severe) exacerbations | 29 | 25% |
Blood eosinophil levels | 20 | 17% |
Fractional exhaled nitric oxide (FeNO) | 18 | 15% |
Change in Forced vital capacity (FVC) | 17 | 15% |